A Study of CUSP06 in Patients with Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- OnCusp Therapeutics, Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT06234423
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
© Copyright 2025. All Rights Reserved by MedPath